{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:38:28Z","timestamp":1791844708100,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>New-generation self-expanding transcatheter aortic heart valves (THV) were designed to overcome technical constraints of their preceding generations. We sought to compare the efficacy and safety of the self-expanding ACURATE neo2 (Neo2) versus Evolut PRO (PRO) devices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seven hundred nine patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) with either Neo2 (<jats:italic>n<\/jats:italic>\u2009=\u2009496) or PRO (<jats:italic>n<\/jats:italic>\u2009=\u2009213) were included. Propensity score matching (PSM) was performed to account for differences in baseline characteristics. In-hospital and 30-day clinical outcomes were evaluated according to Valve Academic Research Consortium-3 criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Baseline characteristics were comparable between both groups after PSM (Neo2: <jats:italic>n<\/jats:italic>\u2009=\u2009155, Evolut Pro: <jats:italic>n<\/jats:italic>\u2009=\u2009155). Technical success rates were high in both groups (Neo2: 94.8% vs PRO: 97.4%; <jats:italic>p<\/jats:italic>\u2009=\u20090.239). Need for permanent pacemaker implantation was less frequent with Neo2 compared with PRO (7.5% vs 20.6%; <jats:italic>p<\/jats:italic>\u2009=\u20090.002), whereas major vascular complications were more frequent with Neo2 (Neo2: 11.6% vs PRO: 4.5%; <jats:italic>p<\/jats:italic>\u2009=\u20090.022). Intended valve performance at discharge was high in both groups without relevant differences among groups (Neo2: 97.4% vs. 95.3%; <jats:italic>p<\/jats:italic>\u2009=\u20090.328).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Short-term outcomes after TAVI using latest-generation self-expanding THV were excellent, with overall low rates of adverse events. However, Neo2 was associated with lower pacemaker rates and reduced the prevalence of moderate\u2013severe paravalvular leakage. Transprosthetic gradients after TAVI were higher with Neo2 compared with PRO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02194-4","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T09:02:44Z","timestamp":1682672564000},"page":"38-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-6080","authenticated-orcid":false,"given":"Tobias","family":"Rheude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Landt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bleiziffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Renker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Neuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhakim","family":"Allali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja K.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Martin","family":"Wambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Widder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector A.","family":"Alvarez-Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erion","family":"Xhepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2194_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","volume":"77","author":"WC Members","year":"2021","unstructured":"Members WC, Otto CM, Nishimura RA et al (2021) 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77:450\u2013500","journal-title":"J Am Coll Cardiol"},{"key":"2194_CR2","doi-asserted-by":"crossref","unstructured":"Rheude T, Pellegrini C, Allali A et al (2022) Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut. Int J Cardiol 357:115\u2013120","DOI":"10.1016\/j.ijcard.2022.03.043"},{"key":"2194_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4244\/EIJ-D-22-00289","volume":"18","author":"A Scotti","year":"2022","unstructured":"Scotti A, Pagnesi M, Kim W-K et al (2022) Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2. EuroIntervention 18:804\u2013811","journal-title":"EuroIntervention"},{"key":"2194_CR4","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.jcin.2020.07.013","volume":"13","author":"T Rheude","year":"2020","unstructured":"Rheude T, Pellegrini C, Lutz J et al (2020) Transcatheter aortic valve replacement with balloon-expandable valves: comparison of SAPIEN 3 ultra versus SAPIEN 3. JACC Cardiovasc Interv 13:2631\u20132638","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695\u20131705","journal-title":"N Engl J Med"},{"key":"2194_CR6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ et al (2019) Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 380:1706\u20131715","journal-title":"N Engl J Med"},{"key":"2194_CR7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.120.051547","volume":"142","author":"C Tamburino","year":"2020","unstructured":"Tamburino C, Bleiziffer S, Thiele H et al (2020) Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial. Circulation 142:2431\u20132442","journal-title":"Circulation"},{"key":"2194_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","volume":"394","author":"J Lanz","year":"2019","unstructured":"Lanz J, Kim W-K, Walther T et al (2019) Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 394:1619\u20131628","journal-title":"Lancet"},{"key":"2194_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jcin.2022.02.027","volume":"15","author":"A Buono","year":"2022","unstructured":"Buono A, Gorla R, Ielasi A et al (2022) Transcatheter aortic valve replacement with self-expanding ACURATE neo2: postprocedural hemodynamic and short-term clinical outcomes. JACC Cardiovasc Interv 15:1101\u20131110","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR10","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s00392-021-01882-3","volume":"110","author":"H M\u00f6llmann","year":"2021","unstructured":"M\u00f6llmann H, Holzhey DM, Hilker M et al (2021) The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes. Clin Res Cardiol 110:1912\u20131920","journal-title":"Clin Res Cardiol"},{"key":"2194_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4244\/EIJ-D-22-00164","volume":"18","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, Rheude T, Renker M et al (2022) ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation. EuroIntervention 18:987\u2013995","journal-title":"EuroIntervention"},{"key":"2194_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4244\/EIJ-D-20-00279","volume":"16","author":"G Manoharan","year":"2020","unstructured":"Manoharan G, Grube E, Van Mieghem NM et al (2020) Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study. EuroIntervention 16:850\u2013857","journal-title":"EuroIntervention"},{"key":"2194_CR13","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","volume":"42","author":"Committee V-3 W, VARC-3 WRITING COMMITTEE, G\u00e9n\u00e9reux P","year":"2021","unstructured":"Committee V-3 W, VARC-3 WRITING COMMITTEE, G\u00e9n\u00e9reux P et al (2021) Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J 42:1825\u20131857","journal-title":"Eur Heart J"},{"key":"2194_CR14","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00392-021-01918-8","volume":"110","author":"L Voigtl\u00e4nder","year":"2021","unstructured":"Voigtl\u00e4nder L, Kim W-K, Mauri V et al (2021) Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves. Clin Res Cardiol 110:1957\u20131966","journal-title":"Clin Res Cardiol"},{"key":"2194_CR15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.jcin.2017.06.026","volume":"10","author":"O Husser","year":"2017","unstructured":"Husser O, Kim W-K, Pellegrini C et al (2017) Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv 10:2078\u20132087","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/jama.2014.3316","volume":"311","author":"M Abdel-Wahab","year":"2014","unstructured":"Abdel-Wahab M, Mehilli J, Frerker C et al (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311:1503\u20131514","journal-title":"JAMA"},{"key":"2194_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jcin.2019.08.035","volume":"13","author":"JK Forrest","year":"2020","unstructured":"Forrest JK, Kaple RK, Tang GHL et al (2020) Three generations of self-expanding transcatheter aortic valves: a report from the STS\/ACC TVT Registry. JACC Cardiovasc Interv 13:170\u2013179","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcin.2018.11.036","volume":"12","author":"M Pagnesi","year":"2019","unstructured":"Pagnesi M, Kim W-K, Conradi L et al (2019) Transcatheter aortic valve replacement with next-generation self-expanding devices: a multicenter, retrospective, propensity-matched comparison of Evolut PRO versus acurate neo transcatheter heart valves. JACC Cardiovasc Interv 12:433\u2013443","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ehjqcco\/qcaa089","volume":"7","author":"F Bruno","year":"2021","unstructured":"Bruno F, D\u2019Ascenzo F, Vaira MP et al (2021) Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis. Eur Heart J Qual Care Clin Outcomes 7:143\u2013153","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2194_CR20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/eurheartj\/ehx785","volume":"39","author":"PJ van Rosendael","year":"2018","unstructured":"van Rosendael PJ, Delgado V, Bax JJ (2018) Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J 39:2003\u20132013","journal-title":"Eur Heart J"},{"key":"2194_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcin.2017.10.014","volume":"11","author":"JK Forrest","year":"2018","unstructured":"Forrest JK, Mangi AA, Popma JJ et al (2018) Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap. JACC Cardiovasc Interv 11:160\u2013168","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacc.2017.06.045","volume":"70","author":"E Grube","year":"2017","unstructured":"Grube E, Van Mieghem NM, Bleiziffer S et al (2017) Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the International FORWARD Study. J Am Coll Cardiol 70:845\u2013853","journal-title":"J Am Coll Cardiol"},{"key":"2194_CR23","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jcin.2018.03.018","volume":"11","author":"GHL Tang","year":"2018","unstructured":"Tang GHL, Zaid S, Michev I et al (2018) \u201cCusp-Overlap\u201d view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv 11:1663\u20131665","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcin.2021.10.002","volume":"15","author":"I Pascual","year":"2022","unstructured":"Pascual I, Hern\u00e1ndez-Vaquero D, Alperi A et al (2022) Permanent pacemaker reduction using cusp-overlapping projection in TAVR: a propensity score analysis. JACC Cardiovasc Interv 15:150\u2013161","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jcin.2022.03.005","volume":"15","author":"A Aladham","year":"2022","unstructured":"Aladham A, Gada H, Wang Y et al (2022) Incidence of permanent pacemaker implantation using the cusp overlap technique: a large single-center analysis. JACC Cardiovasc Interv 15:1006\u20131008","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4244\/EIJ-D-18-01060","volume":"15","author":"G Costa","year":"2019","unstructured":"Costa G, Zappulla P, Barbanti M et al (2019) Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention 15:875\u2013883","journal-title":"EuroIntervention"},{"key":"2194_CR27","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1093\/eurheartj\/ehz924","volume":"41","author":"L Faroux","year":"2020","unstructured":"Faroux L, Chen S, Muntan\u00e9-Carol G et al (2020) Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. Eur Heart J 41:2771\u20132781","journal-title":"Eur Heart J"},{"key":"2194_CR28","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.3390\/jcm10204627","volume":"10","author":"A R\u00fcck","year":"2021","unstructured":"R\u00fcck A, Kim W-K, Kawashima H et al (2021) Paravalvular aortic regurgitation severity assessed by quantitative aortography: ACURATE neo2 versus ACURATE neo transcatheter aortic valve implantation. J Clin Med 10:4627","journal-title":"J Clin Med"},{"key":"2194_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.4244\/EIJ-D-20-01293","volume":"17","author":"K Chau","year":"2022","unstructured":"Chau K, Chau KC, Chen S et al (2022) Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study. EuroIntervention 17:1053\u20131060","journal-title":"EuroIntervention"},{"key":"2194_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.114.013947","volume":"131","author":"PF Ludman","year":"2015","unstructured":"Ludman PF, Moat N, de Belder MA et al (2015) Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 131:1181\u20131190","journal-title":"Circulation"},{"key":"2194_CR31","first-page":"1970","volume":"103","author":"R Zahn","year":"2017","unstructured":"Zahn R, Werner N, Gerckens U et al (2017) Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis. Heart 103:1970\u20131976","journal-title":"Heart"},{"key":"2194_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4244\/EIJ-D-21-00784","volume":"18","author":"T Okuno","year":"2022","unstructured":"Okuno T, Tomii D, Heg D et al (2022) Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation. EuroIntervention 18:33\u201342","journal-title":"EuroIntervention"},{"key":"2194_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jcin.2019.08.041","volume":"13","author":"D Regazzoli","year":"2020","unstructured":"Regazzoli D, Chiarito M, Cannata F et al (2020) Transcatheter self-expandable valve implantation for aortic stenosis in small aortic annuli: the TAVI-SMALL Registry. JACC Cardiovasc Interv 13:196\u2013206","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR34","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.jcin.2018.07.050","volume":"11","author":"M Abdelghani","year":"2018","unstructured":"Abdelghani M, Mankerious N, Allali A et al (2018) Bioprosthetic valve performance after transcatheter aortic valve replacement with self-expanding versus balloon-expandable valves in large versus small aortic valve annuli: insights from the CHOICE Trial and the CHOICE-Extend Registry. JACC Cardiovasc Interv 11:2507\u20132518","journal-title":"JACC Cardiovasc Interv"},{"key":"2194_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.4244\/EIJ-D-19-00710","volume":"15","author":"T Rheude","year":"2020","unstructured":"Rheude T, Pellegrini C, Cassese S et al (2020) Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves. EuroIntervention 15:1233\u20131239","journal-title":"EuroIntervention"},{"key":"2194_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjcard.2020.10.018","volume":"138","author":"T Rheude","year":"2021","unstructured":"Rheude T, Pellegrini C, Stortecky S et al (2021) Meta-analysis of bioprosthetic valve thrombosis after transcatheter aortic valve implantation. Am J Cardiol 138:92\u201399","journal-title":"Am J Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02194-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T16:04:13Z","timestamp":1706112253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02194-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2194"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02194-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TR received lecture fees from SIS Medical and AstraZeneca. AA is a proctor and consultant for Boston Scientific. TKR: Speaker\u2019 honoraria from Medtronic and Boston Scientific. WK received personal fees from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Meril Life Sciences, Shockwave Med. MJ received lecture fees and research grants from Edwards Lifesciences and Boston Scientific and is a consultant for Biotronik and Orbus Neich. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}